Development and validation of a clinical and genetic model for predicting risk of severe COVID-19
Gillian S. Dite(University of Melbourne), Richard Allman(Genetic Technologies (Australia)), Nicholas M. Murphy(Genetic Technologies (Australia))
Cited by 34
Related Papers
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
|The Lancet Oncology|2016|213
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
|Human Molecular Genetics|2011|173
An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case–control study
|PLoS ONE|2021|48
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
|Breast Cancer Research|2014|46